NCT00302250View on ClinicalTrials.gov

The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

December 31, 2006

Conditions
Cardiovascular Disease
Interventions
DRUG

ALT-711 (alagebrium chloride)

Trial Locations (1)

21287

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart and Lung Institute

OTHER

lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00302250 - The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension | Biotech Hunter | Biotech Hunter